Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease - PubMed (original) (raw)
Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease
Michele Rossini et al. Kidney Int. 2005 Dec.
Free article
Abstract
Background: The fibroblast growth factor (FGF) family has functions in development, cell proliferation, migration, and differentiation. While FGF-2 induces fibrosis, the role of FGF-1 in inflammation and fibrosis is less defined. We examined the expression of FGF-1 and FGF receptor (FGFR-1) to determine if renal diseases with varying etiologies of inflammation, including lupus nephritis (LN), acute interstitial nephritis (AIN) and acute rejection superimposed on chronic allograft nephropathy (CAN), showed varying patterns of expression. We also examined the expression of fibroblast-specific protein-1 (FSP-1), which has been linked to epithelial-mesenchymal transition (EMT) and fibrosis, to determine whether it was linked to potential profibrotic and inflammatory FGF-1 mechanisms.
Methods: Proliferative LN (PLN) (N= 12), nonproliferative lupus nephritis (NPLN) (N= 5), AIN (N= 6), CAN (N= 4), and normal kidneys (N= 3) were studied. FGF, FGFR-1, and FSP-1 were localized by immunohistochemistry, and intensity scored on a 0 to 3+ scale. Double staining with CD68 and separate immunohistochemical staining for CD4 and CD8 with serial sections analysis were done to identify if T lymphocytes or macrophages showed staining for FGF-1 and FGFR-1 or FSP-1.
Results: In normal kidneys, FGF-1 was expressed in mesangial cells (0.67 +/- 0.58), glomerular endothelial (0.67 +/- 0.58), visceral, and parietal epithelial cells (1.67 +/- 0.58). FGFR-1 showed a similar pattern of staining but also was expressed in tubular epithelium, and arterial endothelium and smooth muscle. Expression of FGF-1 was increased over normal in glomerular parenchymal cells only in CAN in podocytes (2.30 +/- 0.58 vs. 3.00 +/- 0.00) (P < 0.05) and parietal epithelial cells (1.67 +/- 0.58 vs. 2.25 +/- 0.50) (P < 0.05). Infiltrating glomerular and interstitial inflammatory cells in diseased glomeruli also expressed FGF-1 and FGFR-1. Tubular cells expressed slightly increased FGFR-1 in renal diseases vs. normal, whereas tubules remained negative for FGF-1 in diseased kidneys. FSP-1 expression was prominent in the interstitium in all kidneys with interstitial inflammation, and most prominent in CAN. Interstitial FSP-1+ cells were consistent with a myofibroblast-type morphology, and did not stain with CD-68. FSP-1 expression was closely associated with inflammatory cells expressing FGF-1 and FGFR-1. FSP-1 also showed positivity within crescents and occasional podocytes in PLN.
Conclusion: The expression of FGF-1 and FGFR-1 in infiltrating lymphocytes and macrophages, and of FGFR-1 in tubules, is supportive, but does not prove causality, of the possibility that FGF-1 might have both autocrine and paracrine functions in renal inflammation. However, the initial stimulus for renal inflammation, whether immune complex, hypersensitivity or rejection, did not alter expression patterns of FGF-1 or its receptor. The colocalization of inflammatory infiltrates with interstitial fibrosis supports the possibility of a contribution of FGF-1 for chemotaxis and associated fibrosis, further supported by interstitial FSP-1 expression closely associated with these inflammatory cells expressing FGF-1 and FGFR-1.
Similar articles
- Immunolocalization of FGF-1 and receptors in glomerular lesions associated with chronic human renal allograft rejection.
Kerby JD, Verran DJ, Luo KL, Ding Q, Tagouri Y, Herrera GA, Diethelm AG, Thompson JA. Kerby JD, et al. Transplantation. 1996 Jul 27;62(2):190-200. doi: 10.1097/00007890-199607270-00008. Transplantation. 1996. PMID: 8755815 - Angiotensin inhibition in the developing kidney; tubulointerstitial effect.
Yoo KH, Yim HE, Bae ES, Hong YS. Yoo KH, et al. Pediatr Res. 2019 Apr;85(5):724-730. doi: 10.1038/s41390-019-0288-9. Epub 2019 Jan 25. Pediatr Res. 2019. PMID: 30700837 - Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation.
Strutz F, Zeisberg M, Hemmerlein B, Sattler B, Hummel K, Becker V, Müller GA. Strutz F, et al. Kidney Int. 2000 Apr;57(4):1521-38. doi: 10.1046/j.1523-1755.2000.00997.x. Kidney Int. 2000. PMID: 10760088 - Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
Haas M. Haas M. Curr Opin Nephrol Hypertens. 2014 May;23(3):245-50. doi: 10.1097/01.mnh.0000444811.26884.2d. Curr Opin Nephrol Hypertens. 2014. PMID: 24626060 Review. - Predominant tubulointerstitial lupus nephritis.
Singh AK, Ucci A, Madias NE. Singh AK, et al. Am J Kidney Dis. 1996 Feb;27(2):273-8. doi: 10.1016/s0272-6386(96)90553-3. Am J Kidney Dis. 1996. PMID: 8659506 Review.
Cited by
- Macrophage contribution to the survival of transferred expanded skin flap through angiogenesis.
Huang Z, Ding J, Song Y, Liu W, Dong C, Zhang Y, Wang T, Du J, Xiong S, He Q, Yu Z, Ma X. Huang Z, et al. Ann Transl Med. 2023 Mar 31;11(6):248. doi: 10.21037/atm-22-1558. Epub 2023 Jan 30. Ann Transl Med. 2023. PMID: 37082668 Free PMC article. - Relaxin inhibits renal fibrosis and the epithelial-to-mesenchymal transition via the Wnt/β-catenin signaling pathway.
Feiteng C, Lei C, Deng L, Chaoliang X, Zijie X, Yi S, Minglei S. Feiteng C, et al. Ren Fail. 2022 Dec;44(1):513-524. doi: 10.1080/0886022X.2022.2044351. Ren Fail. 2022. PMID: 35311469 Free PMC article. - Impact of FGF1 on human periodontal ligament fibroblast growth, osteogenic differentiation and inflammatory reaction in vitro.
Knaup I, Symmank J, Bastian A, Neuss S, Pufe T, Jacobs C, Wolf M. Knaup I, et al. J Orofac Orthop. 2022 Oct;83(Suppl 1):42-55. doi: 10.1007/s00056-021-00363-6. Epub 2021 Dec 7. J Orofac Orthop. 2022. PMID: 34874457 English. - Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis.
Chen Y, Yan Q, Lv M, Song K, Dai Y, Huang Y, Zhang L, Zhang C, Gao H. Chen Y, et al. Cell Death Dis. 2020 Nov 20;11(11):994. doi: 10.1038/s41419-020-03199-x. Cell Death Dis. 2020. PMID: 33219209 Free PMC article. - FGF/FGFR signaling in health and disease.
Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, Ni Z, Zhang B, Zhang D, Luo F, Chen H, Sun X, Feng JQ, Qi H, Chen L. Xie Y, et al. Signal Transduct Target Ther. 2020 Sep 2;5(1):181. doi: 10.1038/s41392-020-00222-7. Signal Transduct Target Ther. 2020. PMID: 32879300 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous